| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(79)90634-X |
| P8608 | Fatcat ID | release_vpndlnt74nhw7i545m4dhqmyou |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000293437990634X?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:000293437990634X?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 42314 |
| P2093 | author name string | H. E. Paulus | |
| C. Restivo | |||
| E. S. Leib | |||
| P2860 | cites work | Clinical Research | Q27710467 |
| The Journal of Rheumatology | Q7743623 | ||
| Deutsches Archiv fur klinische Medizin | Q27710730 | ||
| The Quarterly Journal of Medicine | Q27712876 | ||
| Bulletin of the Johns Hopkins Hospital | Q27718094 | ||
| Association between polyarteritis and Australia antigen | Q34201801 | ||
| Biologic and clinical significance of cryoglobulins. A report of 86 cases | Q34204386 | ||
| Periarteritis nodosa; a critical review | Q35665319 | ||
| Vasculitis with hepatitis B antigenemia: long-term observation in nine patients | Q39069288 | ||
| Immune complexes in hepatitis B antigen-associated periarteritis nodosa. Detection by antibody-dependent cell-mediated cytotoxicity and the Raji cell assay | Q39146913 | ||
| Arthritis rounds. Pneumocystis carinii associated with polyarteritis and immunosuppressive therapy | Q39150441 | ||
| Cyclophosphamide-induced remissions in advanced polyarteritis nodosa | Q39190353 | ||
| Immune Complex Disease in Experimental Animals and Man | Q39941757 | ||
| Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa | Q44019895 | ||
| Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity | Q47717788 | ||
| Long-term follow-up study of periarteritis nodosa. | Q53794085 | ||
| Hepatitis associated antigen and periarteritis nodosa (PAN) | Q68751805 | ||
| Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate | Q69107515 | ||
| A chromosome translocation in association with periarteritis nodosa and macroglobulinemia | Q70073218 | ||
| The natural history of polyarteritis | Q74639435 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polyarteritis nodosa | Q745162 |
| P304 | page(s) | 941-947 | |
| P577 | publication date | 1979-12-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Immunosuppressive and corticosteroid therapy of polyarteritis nodosa | |
| P478 | volume | 67 |
| Q72429662 | A clinical approach to systemic vasculitis |
| Q33571394 | A foot-drop case |
| Q35228152 | AAEM minimonograph #38: Neuropathies in connective tissue disease |
| Q40546164 | Acute, painful, and swollen testicle as the presenting feature in polyarteritis nodosa |
| Q37052726 | Advances in the treatments of systemic vasculitides |
| Q43599058 | Aggressive retinal vasculitis in polyarteritis nodosa |
| Q34360694 | An unusual complication of polyarteritis nodosa with massive retroperitoneal hemorrhage: a case report. |
| Q69773257 | Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis |
| Q37799087 | Azathioprine, cyclophosphamide and chlorambucil |
| Q73298935 | Bilateral vocal fold paralysis caused by polyarteritis nodosa |
| Q38877243 | Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa. |
| Q33558707 | Central nervous system polyarteritis nodosa |
| Q73029473 | Churg-Strauss syndrome |
| Q69898024 | Clinical features, treatment and outcome of polyarteritis nodosa |
| Q34395174 | Clinical management and treatment of vasculitis |
| Q40154586 | Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases |
| Q44544640 | Course of cerebral lesions in a patient with periarteritis nodosa studied by magnetic resonance imaging |
| Q35579503 | Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis. |
| Q37608090 | Cutaneous periarteritis nodosa |
| Q40807892 | Cyclophosphamide treatment in polyarteritis nodosa |
| Q39822812 | Cytotoxic agents for use in dermatology. I. |
| Q37775922 | Cytotoxic drugs in the treatment of skin disease |
| Q38043946 | Damage assessment in ANCA-associated vasculitis. |
| Q44547493 | De Novo Systemic Vasculitis in a Renal Transplant Recipient |
| Q52488954 | Development and evaluation of a rapid, semi-automatic micro-method for CH50 estimation using a computer program. |
| Q70020322 | Diagnostic and therapeutic approach to the patient with vasculitis |
| Q40895072 | Disease assessment and management of the vasculitides |
| Q34157764 | Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis |
| Q34570998 | Gastrointestinal involvement in polyarteritis nodosa (1986-2000): presentation and outcomes in 24 patients |
| Q46469656 | Glucocorticoids: importance in the treatment of vasculitis |
| Q49084368 | HLA-B27 positive ankylosing spondylitis and polyarteritis nodosa: a case report |
| Q36334139 | Hemorrhagic Stroke due to Cerebral Vasculitis and the Role of Immunosuppressive Therapy |
| Q37580774 | Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations |
| Q24246358 | Immunosuppressive treatment for non-systemic vasculitic neuropathy |
| Q35199878 | Indications of plasma exchanges for systemic vasculitides |
| Q72574923 | Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis |
| Q69891017 | Localized polyarteritis nodosa: cases involving the lower extremities and the breast |
| Q38591478 | Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders |
| Q24604335 | Medium-size-vessel vasculitis |
| Q41635876 | Methotrexate use in systemic vasculitis |
| Q36723568 | Microscopic polyarteritis: clinical features and treatment |
| Q44178579 | Muscle-localized tumorlike polyarteritis nodosa |
| Q36167711 | Muscular polyarteritis nodosa as a cause of fever of undetermined origin: a case report and review of the literature |
| Q40082544 | Necrotizing vasculitis |
| Q30667363 | Neurologic manifestations of systemic vasculitis |
| Q24679901 | Neurology of the vasculitides and connective tissue diseases |
| Q40066118 | Novel strategy for the treatment of refractory vasculitis syndrome |
| Q72660324 | Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy |
| Q40869143 | Optimisation of cyclophosphamide therapy in systemic vasculitis |
| Q46458382 | Polyarteritis group of systemic vasculitis--new diagnostic criteria |
| Q34499555 | Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations |
| Q36721167 | Polyarteritis nodosa in a young man, a ten-year delay in diagnosis |
| Q36715693 | Polyarteritis nodosa involving the hard palate: a case report |
| Q37595377 | Polyarteritis nodosa presenting as bilateral sudden onset cochleo-vestibular failure in a young woman |
| Q74714031 | Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome |
| Q41641735 | Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment |
| Q41423916 | Polyarteritis nodosa-induced pancreaticoduodenal artery aneurysmal rupture |
| Q72465107 | Polyarteritis nodosa: Regression of arterial aneurysms following immunosuppressive and corticosteroid therapy |
| Q50583980 | Polyarthritis Confined to Lower Extremities |
| Q45257869 | Primary vasculitis in a Norwegian community hospital: a retrospective study. |
| Q50598769 | Profound sensorineural hearing loss in polyarteritis nodosa. An atypical case of Cogan's syndrome. |
| Q69866980 | Renal vasculitis |
| Q64068898 | Severe Disabling Myalgia as an Initial Presentation of Polyarteritis Nodosa |
| Q33564864 | Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis |
| Q67888842 | Spinal cord compression in polyarteritis nodosa |
| Q85066063 | Sudden death due to polyarteritis nodosa |
| Q69471429 | Systemic vasculitis in a rheumatology unit over a two year period |
| Q38774997 | Systemic vasculitis with renal involvement--a review |
| Q36175907 | The necrotising vasculitides |
| Q37467895 | The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU). |
| Q38195146 | The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders |
| Q72550410 | The wide clinical spectrum of polyarteritis nodosa with cutaneous involvement* |
| Q72463676 | Therapeutic briefs. III |
| Q58622230 | Traitement des vascularites systémiques |
| Q72530532 | Treatment of Vasculitis |
| Q33621708 | Treatment of peripheral neuropathies |
| Q38219932 | Treatment of severe and/or refractory ANCA-associated vasculitis |
| Q34403507 | Treatment of vasculitis |
| Q74514106 | Treatments for systemic vasculitides |
| Q77424544 | Uncommon features of polyarteritis nodosa: psychosis and angio-oedema |
| Q39822823 | Use of cytotoxic drugs in dermatologic diseases. II. |
| Q40086415 | Vasculitic Diseases |
| Q67494311 | Vasculitic neuropathy |
| Q33642739 | Vasculitic peripheral ulcerative keratitis |
| Q41641704 | Vasculitis and the nervous system. Historical perspective and overview |
| Q72233182 | Vasculitis in childhood |
| Q72170387 | [Allergic angiitis with granulomatosis: the Churg and Strauss syndrome] |
| Q73361395 | [Clinical symptomatology and prognosis of periarteritis nodosa in the elderly. Retrospective study of 25 periarteritis nodosa cases in young adults and 22 cases in aged patients] |
| Q69091946 | [Inflammatory proteins and systemic diseases] |
| Q68522143 | [Necrotizing vasculitis with interstitial myositis localized in the calf: a new case] |
| Q69372849 | [Renal involvement in necrotizing angiitis] |
Search more.